CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Acurx Pharmaceuticals, Inc. - ACXP CFD

    2.79
    1.76%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.26
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.84
    Open* 2.81
    1-Year Change* 14.69%
    Day's Range* 2.73 - 2.84
    52 wk Range N/A
    Average Volume (10 days) N/A
    Average Volume (3 months) N/A
    Market Cap N/A
    P/E Ratio N/A
    Shares Outstanding N/A
    Revenue N/A
    EPS N/A
    Dividend (Yield %) N/A
    Beta N/A
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 17, 2023 2.98 -0.10 -3.25% 3.08 3.08 2.89
    Mar 16, 2023 3.13 -0.15 -4.57% 3.28 3.34 3.08
    Mar 15, 2023 3.24 -0.09 -2.70% 3.33 3.33 3.09
    Mar 14, 2023 3.42 0.04 1.18% 3.38 3.47 3.32
    Mar 13, 2023 3.23 0.09 2.87% 3.14 3.34 3.14
    Mar 10, 2023 3.16 -0.11 -3.36% 3.27 3.39 3.08
    Mar 9, 2023 3.27 -0.11 -3.25% 3.38 3.47 3.11
    Mar 8, 2023 3.42 -0.06 -1.72% 3.48 3.71 3.36
    Mar 7, 2023 3.48 0.06 1.75% 3.42 3.52 3.15
    Mar 6, 2023 3.30 -0.09 -2.65% 3.39 3.57 3.28
    Mar 3, 2023 3.48 0.11 3.26% 3.37 3.58 3.37
    Mar 2, 2023 3.33 0.19 6.05% 3.14 3.36 3.13
    Mar 1, 2023 3.18 -0.02 -0.63% 3.20 3.20 3.04
    Feb 28, 2023 3.22 0.08 2.55% 3.14 3.24 3.11
    Feb 27, 2023 3.09 -0.06 -1.90% 3.15 3.23 3.02
    Feb 24, 2023 3.13 0.01 0.32% 3.12 3.18 3.01
    Feb 23, 2023 3.14 0.05 1.62% 3.09 3.26 3.03
    Feb 22, 2023 3.08 -0.05 -1.60% 3.13 3.19 2.90
    Feb 21, 2023 3.28 -0.19 -5.48% 3.47 3.47 3.08
    Feb 17, 2023 3.43 0.06 1.78% 3.37 3.52 3.37

    Acurx Pharmaceuticals, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total revenue 0 0 0 0
    Total Operating Expense 12.0928 12.7477 4.60004 5.93125
    Selling/General/Admin. Expenses, Total 7.33851 10.784 2.39706 2.42117
    Research & Development 4.75427 2.03018 2.20298 3.51009
    Operating Income -12.0928 -12.7477 -4.60004 -5.93125
    Net Income Before Taxes -12.0928 -12.7477 -4.60004 -5.93125
    Net Income After Taxes -12.0928 -12.7477 -4.60004 -5.93125
    Net Income Before Extra. Items -12.0928 -12.7477 -4.60004 -5.93125
    Net Income -12.0928 -12.7477 -4.60004 -5.93125
    Income Available to Common Excl. Extra. Items -12.0928 -12.7477 -4.60004 -5.93125
    Income Available to Common Incl. Extra. Items -12.0928 -12.7477 -4.60004 -5.93125
    Diluted Net Income -12.0928 -12.7477 -4.60004 -5.93125
    Diluted Weighted Average Shares 10.8164 8.53587 9.54116 9.54116
    Diluted EPS Excluding Extraordinary Items -1.118 -1.49343 -0.48213 -0.62165
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -1.118 -1.50122 -0.48213 -0.62165
    Unusual Expense (Income) 0 -0.0665
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0 0 0 0 0
    Total Operating Expense 2.90296 3.26051 3.54159 2.62053 2.67014
    Selling/General/Admin. Expenses, Total 1.88737 1.82786 1.95055 1.70884 1.85125
    Research & Development 1.01558 1.43265 1.59104 0.91169 0.81889
    Unusual Expense (Income) 0 0 0
    Operating Income -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Net Income Before Taxes -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Net Income After Taxes -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Net Income Before Extra. Items -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Net Income -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Income Available to Common Excl. Extra. Items -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Income Available to Common Incl. Extra. Items -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Diluted Net Income -2.90296 -3.26051 -3.54159 -2.62053 -2.67014
    Diluted Weighted Average Shares 11.6394 11.6111 11.1484 10.2632 10.2328
    Diluted EPS Excluding Extraordinary Items -0.24941 -0.28081 -0.31768 -0.25533 -0.26094
    Diluted Normalized EPS -0.24941 -0.28081 -0.31768 -0.25533 -0.26094
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total Current Assets 9.37671 13.2542 3.22402 2.53143
    Cash and Short Term Investments 9.11175 12.9588 3.17541 2.48332
    Cash 9.11175 12.9588 3.17541 2.48332
    Prepaid Expenses 0.26496 0.2953 0.04861 0.0481
    Total Assets 9.37671 13.2542 3.22402 2.53143
    Total Current Liabilities 2.06169 0.84391 0.47256 1.71157
    Payable/Accrued 0.02954 0.06337 0 0.0023
    Accrued Expenses 2.03215 0.78054 0.45593 1.25429
    Notes Payable/Short Term Debt 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0.01663 0
    Other Current Liabilities, Total 0 0.45498
    Total Liabilities 2.06169 0.84391 0.52243 1.71157
    Total Long Term Debt 0 0 0.04988 0
    Long Term Debt 0 0.04988 0
    Total Equity 7.31502 12.4102 2.70159 0.81985
    Common Stock 0.01163 0.01022 16.5022 10.0204
    Retained Earnings (Accumulated Deficit) -38.6411 -26.5483 -13.8006 -9.20057
    Total Liabilities & Shareholders’ Equity 9.37671 13.2542 3.22402 2.53143
    Total Common Shares Outstanding 11.6276 10.2158 9.54116 9.54116
    Additional Paid-In Capital 45.9445 38.9483
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 7.38542 9.37671 10.9452 9.20905 11.3223
    Cash and Short Term Investments 7.17882 9.11175 10.6073 9.0922 11.0829
    Cash 7.17882 9.11175 10.6073 9.0922 11.0829
    Prepaid Expenses 0.2066 0.26496 0.33781 0.11686 0.23945
    Total Assets 7.38542 9.37671 10.9452 9.2593 11.3223
    Total Current Liabilities 2.07398 2.06169 1.18208 0.47388 0.63303
    Payable/Accrued 0.01841 0.02954 0.00594 0.00576 0.00636
    Accrued Expenses 2.05557 2.03215 1.17614 0.46812 0.62667
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Total Liabilities 2.07398 2.06169 1.18208 0.47388 0.63303
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Total Equity 5.31144 7.31502 9.76307 8.78542 10.6893
    Common Stock 0.01167 0.01163 0.01159 0.01026 0.01026
    Additional Paid-In Capital 46.8438 45.9445 45.132 40.6141 39.8975
    Retained Earnings (Accumulated Deficit) -41.544 -38.6411 -35.3806 -31.839 -29.2185
    Total Liabilities & Shareholders’ Equity 7.38542 9.37671 10.9452 9.2593 11.3223
    Total Common Shares Outstanding 11.6718 11.6276 11.5926 10.2632 10.2632
    Other Long Term Assets, Total 0.05025
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Net income/Starting Line -12.0928 -12.7477 -4.60004 -5.93125
    Cash From Operating Activities -7.54229 -5.0137 -3.35156 -3.98527
    Non-Cash Items 3.30236 7.59272 2.04965 0.90043
    Changes in Working Capital 1.24813 0.14128 -0.80117 1.04556
    Cash From Financing Activities 3.6952 14.7971 4.04365 4.45544
    Financing Cash Flow Items 0 0.45498
    Issuance (Retirement) of Stock, Net 3.6952 14.7971 3.97714 4.00046
    Issuance (Retirement) of Debt, Net 0 0.0665 0
    Net Change in Cash -3.8471 9.78344 0.69209 0.47017
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -2.90296 -12.0928 -8.83227 -5.29067 -2.67014
    Cash From Operating Activities -1.93293 -7.54229 -6.0467 -3.86665 -1.876
    Non-Cash Items 0.89938 3.30236 2.4899 1.66585 0.94917
    Changes in Working Capital 0.07065 1.24813 0.29567 -0.24183 -0.15503
    Cash From Financing Activities 3.6952 3.6952 0
    Issuance (Retirement) of Stock, Net 3.6952 3.6952 0
    Issuance (Retirement) of Debt, Net
    Net Change in Cash -1.93293 -3.8471 -2.35151 -3.86665 -1.876
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Luci (David P) Individual Investor 8.7875 1078543 0 2023-04-24
    DeLuccia (Robert J) Individual Investor 8.596 1055045 0 2023-04-24
    Armistice Capital LLC Hedge Fund 7.1698 880000 600000 2023-04-24 HIGH
    Shawah (Robert G) Individual Investor 1.5415 189200 0 2023-04-24
    Sailer (Carl) Individual Investor 0.797 97815 0 2023-04-24
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.7291 89485 5150 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6297 77283 0 2023-03-31 LOW
    Millennium Management LLC Hedge Fund 0.1797 22051 -7045 2023-03-31 HIGH
    Dean (Jack H) Individual Investor 0.1442 17693 0 2023-04-24
    Advisor Group, Inc Investment Advisor 0.1304 16000 4000 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1215 14911 522 2023-03-31 LOW
    Donohue (James J.) Individual Investor 0.1018 12500 0 2023-04-24
    Tocqueville Asset Management LP Investment Advisor/Hedge Fund 0.0823 10100 0 2023-03-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.0753 9246 0 2023-03-31 LOW
    Semmax Financial Advisors, Inc. Investment Advisor 0.0479 5879 0 2022-12-31 LOW
    Scodari (Joseph C) Individual Investor 0.0251 3077 0 2023-04-24
    Belpointe Asset Management LLC Investment Advisor/Hedge Fund 0.0244 3000 0 2023-03-31 MED
    UBS Financial Services, Inc. Investment Advisor 0.0237 2904 168 2023-03-31 LOW
    Tower Research Capital LLC Hedge Fund 0.0235 2890 -5 2023-03-31 HIGH
    Harrison (Thomas L) Individual Investor 0.0125 1539 0 2023-04-24 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    530K+

    Trader

    87K+

    Klien aktif per bulan

    $46M+

    Volume investasi per bulan

    $31M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    259 Liberty Avenue
    STATEN ISLAND
    NEW YORK 10305
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    ETH/USD

    1,905.58 Price
    +4.360% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 5.00

    TSLA

    194.17 Price
    +5.480% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.22

    Oil - Brent

    77.24 Price
    +1.530% 1D Chg, %
    Biaya inap posisi Long -0.0122%
    Biaya inap posisi short -0.0098%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.04

    XRP/USD

    0.49 Price
    +2.820% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00481

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 530.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda